Scancell Ltd

4 clinical trials · Sponsor

Record	Firm	Date
A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection (NCT05047445)	Scancell Ltd	2021-10-01
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) (NCT04079166)	Scancell Ltd	2019-08-19

Every clearance here is in the API, with alerts when new ones post.